Research Course in Translational Radiation Biology and Oncology

Florence, Italy

The course will provide an overview on current research topics in radiation biology and translational radiation oncology. In 2020, a specific highlight will be on Radio-Immunology.



[ Early deadline: 11 August 2020 ]

The course is aimed at radiation oncologists and researchers (e.g. biologists, physicists, statisticians) in training and in practice at any academic level (PhD students, postdoctoral fellows and heads of laboratories) and interested in conducting an active translational research program in radiation biology and radiation oncology. Lectures and tutorials are constructed in such a way that relatively little or no background knowledge of molecular and cellular biology is necessary. A background in preclinical radiobiology and translational research is a plus, but neither of these is a requirement.

Course Directors

  • Martin Pruschy, Biologist, University Hospital Zürich, Zürich (CH)
  • Marie-Catherine Vozenin, Biologist, Centre Hospitalier Universitaire Vaudois, Lausanne (CH)


  • Marc Vooijs, Biologist, Maastricht University Medical Center (MUMC+), Maastricht (NL)
  • Conchita Vens, Biologist, Netherlands Cancer Institute, Amsterdam (NL)
  • Daniel Zips, Radiation Oncologist, Universitätsklinik für Radio-Onkologie, Tübingen (DE)
  • Tim Illidge, Clinical Oncologist, The University of Manchester, Manchester (UK)

The Faculty will be completed with local specialists in specific domains.

Local Organiser

Lorenzo Livi, Radiation Oncologist, University of Florence, Florence (IT)

The purpose of this course is to provide an understanding on current research trends and to outline “hot topics” and research opportunities that have recently emerged in radiation biology and translational radiation oncology to improve clinical practice and outcome. A combination of lectures and tutorial sessions with question/answer sessions are used to comprehend and discuss these topics and how new translational research approaches could address clinical/radiation oncology challenges. The most innovative research aspects in radiation biology of recent years will be presented. Radioimmunotherapy will be the focus of the course in 2020: a whole day will be dedicated to radio-immunology and its translational impact.

Following completion, participants should have sufficient knowledge to read and appreciate the current research literature, understand the concepts and challenges of translational research in the field of radiation oncology, follow new developments in applied radiation biology and radiation oncology, and begin with the development of their own translational research projects with and within their local research groups in this field. Opportunities are provided to discuss research grant proposals.

Learning Outcomes

By the end of this course participants should be familiar with:

  • Current research topics of translational research in the field of radiation oncology
  • Relevant methodologies for translational research in the field of radiation oncology
  • Relevant endpoints of translational research in the field of radiation oncology.

By the end of this course participants should feel motivated to improve:

  • Their basic research projects with translational research aspects
  • Their clinical research projects with translational research aspects.

Course Content

Experts in the field of basic and translational radiation biology will present and discuss current hot topics in basic and translational radiation oncology research in the framework of clinical challenges. Landmark and latest research papers will be discussed and the presented concepts consolidated by tutorials. Research and methodological approaches will be presented and outlined alongside approved research grants by the experts in the respective fields. The course embraces blended learning techniques and integrates small group discussions and activities. Sufficient time slots will be given for participants to discuss their own research interests with experts in the respective fields of research.


Curiosity and a natural passion to increase knowledge, understand or carry out research in order to improve clinical practice.

Teaching Methods

  • 70% of time: lectures and discussion
  • 20% of time: tutorials
  • 10% of time: work on own research proposal.

Methods of Assessment

  • MCQ
  • Evaluation form.


Draft programme available here

Key Words

Radiation biology, radiation oncology, translational research, from bench to bedside and vice versa.

Further Reading

Please consult the ESTRO website page of this course for further information.


Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.


Il Fuligno
Via Faenza, 48
50123 Firenze


We recommend that you search suitable accommodation through one of the online booking websites.  ESTRO will not be providing any accommodation for this course.


ESTRO members can order products at substantially reduced prices. Please note that in order to benefit from the member price, you must renew your membership for 2020 before registering to the course.To benefit from these member rates, please visit the membership page to become a member or renew your membership BEFORE proceeding with your order.



Early rate

Late rate

In-training members*   450 EUR  625 EUR
Members   600 EUR   725 EUR
Non Members   750 EUR  850 EUR

* Members with specialty RadiationTherapist (RTT) may register at the In Training fee

Early rates are applied up to three months before the starting date of the course. 
Late rates are applied three months before the starting date of the course.

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

On-site registration will not be available.

Since the number of participants is limited, late registrants are advised to contact the ESTRO office before payment, to inquire about availability of places. Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.   

In case an unforeseen event would force ESTRO to cancel the meeting, the Society will reimburse the participants fully the registration fees. ESTRO will not be responsible for the refund of travel and accommodation costs.

In case of cancellation, full refund of the registration fee minus 15% for administrative costs may be obtained up to three months before the course and 50% of the fee up to one month before the course. No refund will be made if the cancellation request is postmarked less than one month before the start of the course.

Reduced fees

ESTRO members from economically challenged countries may register at a preferential rate of 350 Euro if three conditions are met:

  1. Only ESTRO members for 2020 are eligible (please make sure your 2020 membership is in order before you apply for the reduced fees)
  2. Only one course per person per year can be subsidized by ESTRO
  3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

Please note: 

  • We can only guarantee a certain number of reduced fees per course
  • Application deadlines are the same as early registration fees (3 months before the course date

List of Economically challenged countries and eligible courses